Delayed Nasdaq  -  05/20 04:00:00 pm EDT
10.73 USD   -3.42%
05/20NEWMARK : Arranges Sale of San Francisco Bay Area Grocery/Drug Anchored Community Shopping Center
05/18Newmark Group Completes $390 Million Sale of Nine Shopping Centers to TA Realty
05/18Newmark Completes $390 Million Sale of Grocery-Anchored Retail Portfolio in Massachusetts and Rhode Island
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Newmark : and Corion Properties Complete $57 Million Sale of Life Sciences Building on USC's Health Science Campus

11/15/2021 | 05:17pm EDT
Newmark and Corion Properties Complete $57 Million Sale of Life Sciences Building on USC's Health Science Campus November 15th, 2021 9:00am
Contact Us
Country Afghanistan Aland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire, Saint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory British Virgin Islands Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos Islands Colombia Comoros Cook Islands Costa Rica Croatia Cuba Curacao Cyprus Czech Republic Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Ivory Coast Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Korea Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territory Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Republic of the Congo Reunion Romania Russia Rwanda Saint Barthelemy Saint Helena Saint Kitts and Nevis Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu U.S. Virgin Islands Uganda Ukraine United Arab Emirates United Kingdom United States United States Minor Outlying Islands Uruguay Uzbekistan Vanuatu Vatican Venezuela Vietnam Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe
Email Address is required

I would like to receive the latest updates from Newmark

By submitting your data through this form, you confirm that you are above the age of 18, that you have read and understood the Privacy Policy, and that you agree to the collection, use and processing of your Personal Information by Newmark & Company Real Estate, Inc. in accordance with said policy.*
Thank you for sharing your information with Newmark!

November 15, 2021 9:00 AM

Newmark [1] announced it has completed the $57 million sale of an approximately 75,272-square-foot, four-story life sciences building in the heart of University of Southern California's Health Science Campus, directly adjacent to USC Norris Hospital. This highly specialized, rare building provides a strong presence in the growing Los Angeles life sciences market for USC's portfolio.

Newmark Co-Head of U.S. Capital MarketsKevin Shannon, Executive Managing Directors Rob Hannan and Ken White and Senior Managing Director Laura Stumm, together with Fred Cordova, Al Grazioli and JoAnn Horeni of Corion Properties Inc., represented the seller, Doheny Eye Institute. USC was represented by CBRE.

The building was constructed in 1976 as a build-to-suit for the Doheny Eye Institute and was available for sale for the first time since its delivery. The building features approximately 14,071 square feet of highly specialized lab space and served as the life science headquarters for Doheny for the last 45 years. Doheny is moving to a 115,000-square-foot building located at 150 Orange Grove Blvd. in Pasadena and should complete the relocation by the end of 2021.

"This was a very competitive bid process reflecting the growing conviction by capital in Los Angeles as a vibrant life science market," said Shannon.

Cordova added, "Ownership of the building, which was the last remaining asset on campus that was not owned by USC, now provides USC with multiple options on repositioning or redevelopment as part of their long-term strategic plan for the campus."

Life sciences continues to be one of real estate's most desirable product types during the pandemic and is projected to grow throughout Los Angeles. L.A. County life sciences companies raised $1.7 billion in financing last year, the most of any county in California, according to Newmark Research. Property owners and tenants are converting existing properties due to lack of available land for ground-up development.

[1] Dba Newmark Knight Frank in California

About Corion Properties, Inc.
Corion Properties, Inc. is a boutique investment management and advisory services firm based in Santa Monica, CA specializing in helping property owners accelerate the performance and monetization of their properties.

About Newmark
Newmark Group, Inc. (Nasdaq: NMRK), together with its subsidiaries ("Newmark"), is a world leader in commercial real estate, seamlessly powering every phase of the property life cycle. Newmark's comprehensive suite of services and products is uniquely tailored to each client, from owners to occupiers, investors to founders, and startups to blue-chip companies. Combining the platform's global reach with market intelligence in both established and emerging property markets, Newmark provides superior service to clients across the industry spectrum. Newmark generated revenues in excess of $2.5 billion for the trailing twelve months ending September 30, 2021. Newmark's company-owned offices, together with its business partners, operate from over 160 offices with approximately 6,200 professionals around the world. To learn more, visit or follow @newmark.

Discussion of Forward-Looking Statements about Newmark

Statements in this document regarding Newmark that are not historical facts are "forward-looking statements" that involve risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements. These include statements about the effects of the COVID-19 pandemic on the Company's business, results, financial position, liquidity and outlook, which may constitute forward-looking statements and are subject to the risk that the actual impact may differ, possibly materially, from what is currently expected. Except as required by law, Newmark undertakes no obligation to update any forward-looking statements. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see Newmark's Securities and Exchange Commission filings, including, but not limited to, the risk factors and Special Note on Forward-Looking Information set forth in these filings and any updates to such risk factors and Special Note on Forward-Looking Information contained in subsequent reports on Form 10-K, Form 10-Q or Form 8-K.


Newmark Group Inc. published this content on 15 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 November 2021 22:14:01 UTC.

© Publicnow 2021
All news about NEWMARK GROUP, INC.
05/20NEWMARK : Arranges Sale of San Francisco Bay Area Grocery/Drug Anchored Community Shopping..
05/18Newmark Group Completes $390 Million Sale of Nine Shopping Centers to TA Realty
05/18Newmark Completes $390 Million Sale of Grocery-Anchored Retail Portfolio in Massachuset..
05/09Newmark Group to Participate in Wolfe Research Virtual Broker Conference
05/03Newmark Buys Retail Advisory Firm Open Realty
05/03NEWMARK GROUP, INC. (NASDAQGS : NMRK) acquired Open Realty Advisors, LLC and Open Realty P..
04/29Newmark Group Posts Higher Q1 Adjusted Earnings, Revenue; Increases Dividend
04/29TRANSCRIPT : Newmark Group, Inc., Q1 2022 Earnings Call, Apr 29, 2022
04/29NEWMARK : Reports First Quarter 2022 Financial Results - Form 8-K
More news
Analyst Recommendations on NEWMARK GROUP, INC.
More recommendations
Financials (USD)
Sales 2022 3 167 M - -
Net income 2022 202 M - -
Net Debt 2022 1 285 M - -
P/E ratio 2022 14,1x
Yield 2022 1,68%
Capitalization 1 981 M 1 981 M -
EV / Sales 2022 1,03x
EV / Sales 2023 1,03x
Nbr of Employees 4 261
Free-Float 73,6%
Duration : Period :
Newmark Group, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NEWMARK GROUP, INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus HOLD
Number of Analysts 5
Last Close Price 10,73 $
Average target price 16,10 $
Spread / Average Target 50,0%
EPS Revisions
Managers and Directors
Barry M. Gosin Chief Executive Officer
James D. Kuhn President & Head-Investor Services
Michael J. Rispoli Chief Financial Officer
Howard William Lutnick Chairman
Sridhar Potineni Chief Information Officer
Sector and Competitors
1st jan.Capi. (M$)
NEWMARK GROUP, INC.-42.62%1 981
CBRE GROUP, INC.-27.22%25 271
KE HOLDINGS INC.-40.01%15 261
ZILLOW GROUP, INC.-35.34%10 040